Atrasentan in Treating Patients With Progressive or Recurrent Malignant Glioma
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing
so they stop growing or die.
PURPOSE: Phase I trial to study the effectiveness of atrasentan in treating patients who have
progressive or recurrent malignant glioma.